Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$17.26 +0.22 (+1.26%)
As of: Sep 9, 2026 · 3:59 PM EDT

Amneal Pharmaceuticals (AMRX) Selling, General & Administrative (2017 - 2026)

Analysis

Amneal Pharmaceuticals (AMRX) Selling, General & Administrative (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 317.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 1.13 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 304.42 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 148.72 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 907.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -43.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 91.66 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 18.24 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 4.64 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 148.72 Mn
Mar 31, 2026 138.86 Mn
Dec 31, 2025 146.46 Mn
Sep 30, 2025 137.82 Mn
Jun 30, 2025 124.27 Mn
Mar 31, 2025 118.29 Mn
Dec 31, 2024 128.69 Mn
Sep 30, 2024 118.69 Mn
Jun 30, 2024 116.46 Mn
Mar 31, 2024 112.60 Mn
Dec 31, 2023 109.00 Mn
Sep 30, 2023 113.01 Mn
Jun 30, 2023 105.57 Mn
Mar 31, 2023 102.10 Mn
Dec 31, 2022 102.16 Mn
Sep 30, 2022 100.07 Mn
Jun 30, 2022 98.81 Mn
Mar 31, 2022 98.67 Mn
Dec 31, 2021 97.22 Mn
Sep 30, 2021 91.40 Mn